When was Trait Bio founded?

Trait Bio was founded in 2018 and raised its 1st funding round within a year of its incorporation.

Where is Trait Bio located?

Trait Bio is headquartered in Los Alamos, United States.

How many employees does Trait Bio have?

As of Aug 31, 2026, the latest employee count at Trait Bio is 20.

Is Trait Bio a funded company?

Trait Bio is a funded company, having raised a total of $47.6M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 25, 2018.

When was the latest funding round of Trait Bio?

Trait Bio's latest funding was a $***** Conventional Debt round on Sep 25, 2023, with participation from 2 investors. Its primary sector is Cannabis HealthTech. Globally, the Cannabis HealthTech sector has seen $12.9M in funding in 2026 to date.

Where does Trait Bio rank among its competitors?

Trait Bio ranks 17th amongst 254 active competitors, of which 29 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Terraflos, which secured $3.5M in Jun, 2026.

Who are the top competitors of Trait Bio?

Trait Bio's top competitors include Sanity Group, Terraflos and ZYUS Life Sciences. Among them, Terraflos secured the most recent funding round in June, 2026.

Trait Bio - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of water-soluble cannabinoid extraction technologies. It develops and commercializes proprietary technologies for extracting and formulating water-soluble cannabinoids. These technologies offer advantages over oil-based products, including improved clarity, increased dosage capacity, and broader applications across various consumer products such as food and beverages, beauty aids, supplements, and pet goods. The company utilizes advanced bio-molecular science, chemistry, and computational analytics in its research and development processes. It has a strong team of scientists and business professionals with experience in various relevant fields.

Website: traitbio.com
Social

Key Metrics

Founded Year

2018

Location

Los Alamos, United States

Stage

Series A

Total Funding

$47.6M in 8 rounds

Latest Funding Round

Conventional Debt, Sep 25, 2023, $*****

Investors

Btomorrow Ventures & 3 more

Ranked

17^th among 254 active competitors

Employee Count

20 as on Aug 31, 2026

Similar Companies

Sanity Group & 305 more

View Trait Bio's full profile

Trait Bio has raised a total funding of $47.6M over 8 rounds. Its first funding round was on Sep 25, 2018. Its latest funding round was a Conventional Debt round on Sep 25, 2023 for $*****. 2 investors participated in its latest round. Trait Bio has 4 institutional investors.

Here is the list of recent funding rounds of Trait Bio:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 25, 2023	4876018	Conventional Debt	2785296	3354303	6244449	5551036
Nov 23, 2022	4842810	Series A	9587075	7427086	3385337	2524072
Jul 22, 2022	4916763	Series A	9003030	9145037	2191773	5699960

Access funding benchmarks and valuations. Sign up today!

View details of Trait Bio's funding rounds and investors

Trait Bio's employee count trend

Trait Bio has 20 employees as of Aug 26. Here is Trait Bio's employee count trend over the years:

Uncover Trait Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Trait Bio include Sanity Group, Terraflos and ZYUS Life Sciences. Here is the list of Top 10 competitors of Trait Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sanity Group 2011, Berlin (Germany), Acquired	Developer of cannabinoid-based pharmaceuticals and well-being products	$109M	HV Capital, TQ Ventures & 19 others	67/100
2nd	Terraflos 2021, Uruguay, Seed	Provider of cannabis medical products	$11.5M	Rainforest Capital, YaaX Capital & 4 others	59/100
3rd	ZYUS Life Sciences 2018, Saskatoon (Canada), Public	Developer of cannabis-derived therapeutics for multiple indications	$19.5M	Keyhorse Capital, Mammoth View	58/100
4th	gLeaf 2014, Frederick (United States), Acquired	Medical cannabis cultivator	$19.4M	Chicago Atlantic	57/100
5th	BOHECO 2013, Mumbai (India), Seed	Provider of cannabis-derived nutritional and wellness products	$9.95M	Absolem Technologies, S R B Buildtech LLP ... & 34 others	56/100
6th	Avicanna 2016, Toronto (Canada), Public	Developer of plant-derived cannabinoid-based products	$5.94M	Orthogonal Thinker, Barn Invest & 1 others	52/100
7th	IMCannabis 2008, Herzliya (Israel), Public	Developer of medical cannabis products	-	-	51/100
8th	Creso Pharma 2015, Perth (Australia), Acquired	Developer of cannabinoid therapeutics for multiple health purposes	-	EverBlu Capital, L1 Capital	51/100
9th	Little Green Pharma 2016, Perth (Australia), Public	Manufacturer of medicinal cannabis for therapeutic use	$1.91M	Fastforward Innovations	49/100
10th	Grow Group 2017, London (United Kingdom), Series C	Developer of cannabis-based medicines for multiple indications	$12.6M	-	46/100
17th	Trait Bio 2018, Los Alamos (United States), Series A	Developer of water-soluble cannabinoid extraction technologies	$47.6M	Btomorrow Ventures, Gotham Green Partners ... & 2 others	43/100